PMID- 35253658
OWN - NLM
STAT- MEDLINE
DCOM- 20220405
LR  - 20220626
IS  - 1875-8894 (Electronic)
IS  - 1874-5393 (Linking)
VI  - 15
IP  - 1
DP  - 2022
TI  - Reliability, minimum detectable change, and minimum clinically important 
      difference of the balance subtest of the Bruininks-Oseretsky test of motor 
      proficiency-second edition in children with cerebral palsy.
PG  - 175-180
LID - 10.3233/PRM-190639 [doi]
AB  - PURPOSE: This study aimed to investigate the internal consistency, inter-rater, 
      and test-retest reliability of the balance subtest of the Bruininks-Oseretsky 
      test of motor proficiency-second edition (BOT-2) and to estimate the minimum 
      detectable change (MDC) and minimum clinically important difference (MCID) of the 
      balance subtest of the BOT-2 in children with cerebral palsy (CP). METHODS: In 
      total, 20 children with CP participated in the present study. Internal 
      consistency, test-retest, and inter-rater reliability were computed to establish 
      reliability of the balance subtest of the BOT-2. The MDC95 was estimated from the 
      standard error of measurement (SEM) to determine a real change for an individual 
      child with CP. The anchor- and distribution-based MCID were calculated to 
      determine the smallest change that might be important to clinicians. For 
      concurrent validity, the correlation between the balance subtest of the BOT-2 and 
      the pediatric balance scale (PBS) were calculated using Spearman's correlation. 
      RESULTS: Internal consistency was good (Cronbach's alpha coefficient = 0.89). The 
      BOT-2 had excellent test-retest (ICC = 0.99, p < 0.001) and inter-rater 
      reliability (ICC = 0.99, p < 0.001). The balance subtest of the BOT-2 had an SEM 
      of 0.70, MDC95 of 9.61, and MCIDs of 2.54 (anchor-based) and 1.38 
      (distribution-based). Additionally, there was a moderate positive correlation 
      between the balance subtest of the BOT-2 and the PBS (Spearman's rho = 0.629, 
      p = 0.003). CONCLUSIONS: Our experimental results indicate that the balance 
      subtest of the BOT-2 had good internal consistency, along with excellent 
      test-retest and inter-rater reliability. The change in scores of an individual 
      child with CP should attain 9.61 points on the balance subtest of the BOT-2 to 
      indicate a clinically important change. The MDC95 and MCID values could be 
      helpful in understanding therapeutic effects and evaluating balancing ability 
      using the balance subtest of the BOT-2 in children with CP.
FAU - Kim, Seong Gil
AU  - Kim SG
AD  - Department of Physical Therapy, Sunmoon University, Asan, Republic of Korea.
FAU - Kim, Do Hyun
AU  - Kim DH
AD  - Department of Physical Therapy, Ansan University, Ansan, Republic of Korea.
LA  - eng
PT  - Journal Article
PL  - Netherlands
TA  - J Pediatr Rehabil Med
JT  - Journal of pediatric rehabilitation medicine
JID - 101490944
SB  - IM
MH  - *Cerebral Palsy
MH  - Child
MH  - Humans
MH  - Reproducibility of Results
OTO - NOTNLM
OT  - Balance
OT  - cerebral palsy
OT  - minimum clinically important difference
OT  - minimum detectable change
OT  - rehabilitation
EDAT- 2022/03/08 06:00
MHDA- 2022/04/06 06:00
CRDT- 2022/03/07 08:47
PHST- 2022/03/08 06:00 [pubmed]
PHST- 2022/04/06 06:00 [medline]
PHST- 2022/03/07 08:47 [entrez]
AID - PRM190639 [pii]
AID - 10.3233/PRM-190639 [doi]
PST - ppublish
SO  - J Pediatr Rehabil Med. 2022;15(1):175-180. doi: 10.3233/PRM-190639.